I think you'll find the revenues from Evamist as Receipts from Licences. They have licensed the drug in the US to KV Pharma. Of course ACR would know the sales figures. I'd guess they aren't great or we'd be told. They have revealed them in the past. I think at AGM time. Need drugs/methods take time for traction but were increasing last time they reported.
Ann: Half Year Accounts and Appendix 4D , page-3
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
-0.002(2.94%) |
Mkt cap ! $19.18M | |||
| Open | High | Low | Value | Volume |
| 6.7¢ | 6.7¢ | 6.5¢ | $29.45K | 447.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11575 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 56756 | 2 |
View Market Depth
| Last trade - 15.53pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.7¢ |
Change
-0.002 ( 1.52 %) |
||||
| Open | High | Low | Volume | ||
| 6.6¢ | 6.7¢ | 6.5¢ | 153530 | ||
| Last updated 15.56pm 27/05/2024 ? | |||||
| ACR (ASX) Chart |